- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Curewin-Hylico Pharma Private Limited covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (81), financial health (65), director (45) and company-foundation signals.
- Operating for 11+ years.
- Company status is Active as per MCA.
- Last balance sheet filed for Mar 2024 - slightly behind.
- Profitable in FY 2023.
- Positive net worth.
- 3 directors on the board.
- Director MADHAVARAM RAVINDER RAO has DIN status "Deactivated due to non-filing of DIR-3 KYC".
About Curewin-Hylico Pharma Private Limited
Curewin-Hylico Pharma Private Limited is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U51101TG2014PTC096702). Business overview includes Pharma (Drug Formulation & Development), incorporated on December 05, 2014 (12+ years old), headquartered in Hyderabad, Telangana, India. The company is currently Active with Active Compliant compliance status.
- Location H No.8-2-310/B/33, Plot No.33, Ground Floor House No.266, Road No.14, Banjara Hills, Hyderabad, Telangana - 500034
- Website curewinhylico.com
Financial Performance of Curewin-Hylico Pharma Private Limited
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Curewin-Hylico Pharma Private Limited (3)
Charges of Curewin-Hylico Pharma Private Limited
| Lender | Amount | Status |
|---|---|---|
|
Hdfc Bank Limited
Creation Date: 21 Dec 2024 |
10.20 Lakh | Open |
|
Axis Bank Limited
Creation Date: 19 Mar 2022 |
1.00 cr | Open |
|
Hdfc Bank Limited
Creation Date: 19 Jan 2022 |
21.95 Lakh | Open |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Trade | - | 100 |
| Trade | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
